Shionogi to acquire Qpex Biopharma for $140m
The Qpex takeover will expand the antimicrobial pipeline of Shionogi. Credit: mwooten from Pixabay. Shionogi has signed a definitive agreement for the acquisition of clinical-stage
The Qpex takeover will expand the antimicrobial pipeline of Shionogi. Credit: mwooten from Pixabay. Shionogi has signed a definitive agreement for the acquisition of clinical-stage
EQS-News: Affluent Medical SA / Key word(s): Agreement Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment 12.07.2024 / 07:45 CET/CEST
Aging may be less about specific “aging genes” and more about how long a gene is. Many of the changes associated with aging could be